Above researches indicate that DNMT3A exerts an important role in lung cancer initiation and progression by enhancing DNA methylation on genes; therefore, DNMT3A and its target genes might act the potential therapeutic molecules. The gene discussed is DNMT3A; the disease is lung carcinoma.